BGF World Healthscience vs BNP Paribas China Equity

BGF World Healthscience vs BNP Paribas China Equity

1. BGF World Healthscience

  • Security

    BGF World Healthscience A2

  • Fee

    2.17%

  • ISIN

    LU0122379950

  • Holdings

    10

2. BNP Paribas China Equity

  • Security

    BNP Paribas China Equity Classic USD Cap

  • Fee

    2.23%

  • ISIN

    LU0823426308

  • Holdings

    16

Fund Holdings

We have information about 20 holdings in BGF World Healthscience, where the largest holding is UnitedHealth (8.2), followed by Eli Lilly (7.01) and Novo Nordisk (6.67). In comparison with BNP Paribas China Equity, we have 22 holdings where Alibaba Group Holding Ltd is the largest holding (9.57), followed by Tencent (9.35) and Xiaomi (6.61).

All Holdings

Here we compare the holdings in BGF World Healthscience and BNP Paribas China Equity.

BGF World Healthscience BNP Paribas China Equity
1. UnitedHealth Group Inc
USA
8.2 %
1. Alibaba Group Holding Ltd
China
9.57 %
2. Eli Lilly and Co
USA
7.01 %
2. Tencent Holdings Ltd
China
9.35 %
3. Novo Nordisk B
Denmark
6.67 %
3. Xiaomi
China
6.61 %
4. Merck & Co Inc
Germany
3.99 %
4. Industrial and Commercial Bank of China Ltd Class H
China
4.22 %
5. Boston Scientific Corp
3.67 %
5. Pop Mart International Group Ltd
China
4.17 %
6. AbbVie Inc
USA
3.61 %
6. Meituan Class B
China
3.16 %
7. Amgen Inc
3.58 %
7. Trip.com Group Ltd
Singapore
2.91 %
8. Sanofi SA
France
3.05 %
8. Ping An Insurance Co
China
2.71 %
9. Abbott Laboratories
USA
3.02 %
9. NetEase ADR
China
2.41 %
10. AstraZeneca
Sweden UK
2.98 %
10. KE Holdings Inc ADR
China
2.4 %
- 11. JD.com Inc
China
2.22 %
- 12. Taiwan Semiconductor Manufacturing Company
Taiwan
1.7 %
- 13. Pinduoduo Inc
China
1.68 %
- 14. China Yangtze Power Co Ltd Class A
China
1.64 %
- 15. BYD Co Ltd Class H
China
1.52 %
- 16. Sunny Optical Technology Company Ltd
China
1.27 %

The list of fund holdings was last updated on June 6, 2025.